SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-094232
Filing Date
2016-04-14
Accepted
2016-04-14 08:32:27
Documents
12
Period of Report
2016-05-25
Effectiveness Date
2016-04-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A v436561_def14a.htm DEF 14A 820368
2 GRAPHIC v436561_pc-1.jpg GRAPHIC 381202
3 GRAPHIC v436561_pc-2.jpg GRAPHIC 609821
4 GRAPHIC v436561_pc-3.jpg GRAPHIC 246827
5 GRAPHIC v436561_pc-4.jpg GRAPHIC 61835
6 GRAPHIC v436561_pc-5.jpg GRAPHIC 738298
7 GRAPHIC v436561_pc-6.jpg GRAPHIC 615224
8 GRAPHIC line.gif GRAPHIC 43
9 GRAPHIC logo_anipharma-black.jpg GRAPHIC 22979
10 GRAPHIC sig_charlotte-arnold.jpg GRAPHIC 9983
11 GRAPHIC spacer.gif GRAPHIC 43
12 GRAPHIC sig_arthur-przybyl.jpg GRAPHIC 31284
  Complete submission text file 0001144204-16-094232.txt   4564205
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 161570505
SIC: 2834 Pharmaceutical Preparations